Novel Therapies Targeting Kidney Disease


Latest Press Releases
Press releases
  • 09 Apr 2026  ·  Regulatory information

    Guard Therapeutics provides information regarding observation status on Nasdaq First North Growth Market

    Read more
  • 31 Mar 2026

    Guard Therapeutics provides update on strategic review

    Read more
  • 05 Feb 2026  ·  Regulatory information

    Guard Therapeutics Announces Changes to the Company’s Management Team

    Read more
  • 05 Feb 2026

    Guard Therapeutics Provides Status Update Regarding Ongoing Strategic Review

    Read more
Show more
In focus
  • 16 Sep 2025 / Presentation

    CEO Tobias Agervald appears on BiotechTV

    Read more
  • 17 Oct 2024 / Presentation

    Guard presents at Redeye Theme "Cardiovascular & Metabolic Diseases Event 2024"

    Read more
  • 23 Sep 2024 / Presentation

    CEO Tobias Agervald appears on BiotechTV

    Read more
  • 19 Sep 2024 / Presentation

    Presentation at Pareto Securities' 15th Annual Healthcare Conference

    Read more
Show more
Upcoming events
  • 20 Apr 2026

    Annual Report 2025 (approximate date)

    Read more
  • 11 May 2026

    Interim Report January–March 2026

    Read more
  • 18 May 2026

    Annual General Meeting 2026

    Read more
  • 20 Aug 2026

    Interim Report January–June 2026

    Read more
Event calendar/Financial calendar